Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Zealand Pharma Aktieselskabet    ZEAL   DK0060257814

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
87(c) 86(c) 84.5(c) 84.5(c) 84(c) Last
51 720 72 300 73 539 32 133 28 169 Volume
-0.57% -1.15% -1.74% 0.00% -0.59% Change
More quotes
Financials ( DKK)
Sales 2017 151 M
EBIT 2017 -244 M
Net income 2017 -260 M
Finance 2017 436 M
Yield 2017 -
Sales 2018 162 M
EBIT 2018 -306 M
Net income 2018 -293 M
Finance 2018 188 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 14,2x
EV / Sales2018 14,8x
Capitalization 2 583 M
More Financials
Company
Zealand Pharma A/S is a biotechnology company.It focuses on the discovery, design and development of peptide based medicines.The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark. 
More about the company
Surperformance© ratings of Zealand Pharma Aktieselska
Trading Rating : Investor Rating :
More Ratings
Latest news on ZEALAND PHARMA AKTIESELSKA
12/08 ZEALAND PHARMA AKTIESELSKABET : initiates the pivotal Phase 3 trial with dasiglu..
12/01 ZEALAND PHARMA AKTIESELSKABET : Employee elected board member change in Zealand ..
11/29 ZEALAND PHARMA AKTIESELSKABET : to attend three U.S. healthcare conferences in D..
11/27 ZEALAND PHARMA AKTIESELSKABET : increases its share capital as a consequence of ..
11/21 ZEALAND PHARMA AKTIESELSKABET : increases its share capital as a consequence of ..
11/20 ZEALAND PHARMA AKTIESELSKABET : Recruitment completed in trial to evaluate the o..
11/14 ZEALAND PHARMA AKTIESELSKABET : Recruitment completed in trial to evaluate the o..
11/13 ZEALAND PHARMA AKTIESELSKABET : will attend the Jefferies Healthcare Conference ..
11/13 ZEALAND PHARMA AKTIESELSKABET : - Interim report for the first nine months of 20..
10/26 ZEALAND PHARMA AKTIESELSKABET : - U.S. FDA grants orphan drug designation to gle..
More news
Sector news : Bio Therapeutic Drugs
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15DJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/12 Sanofi investors hungry for drug progress and deal news
12/09 Tax-loss selling to pressure 2017's losers in December
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/23 Zealand advances dasiglucagon for potential use in artificial pancreas system..
01/04 Sanofi's Soliqua 100/33 now available in U.S
2016 European advisory committee backs Sanofi's diabetes med Suliqua
2016 Zealand Pharma reports Q3 results
2016 Zealand Pharma reports 1h16 results
Chart ZEALAND PHARMA AKTIESELSKA
Duration : Period :
Zealand Pharma Aktieselska Technical Analysis Chart | ZEAL | DK0060257814 | 4-Traders
Technical analysis trends ZEALAND PHARMA AKTIESELSKA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 153  DKK
Spread / Average Target 82%
EPS Revisions
Managers
NameTitle
Britt Meelby Jensen President & Chief Executive Officer
Alf Gunnar Martin Nicklasson Chairman
Mats Blom Chief Financial Officer & Senior Vice President
Adam Steensberg Chief Medical Officer & Senior Vice President
Parker Andrew Chief Science Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ZEALAND PHARMA AKTIESELSKABET-20.66%408
GILEAD SCIENCES6.94%98 689
REGENERON PHARMACEUTICALS5.33%41 789
VERTEX PHARMACEUTICALS96.55%36 888
GENMAB-11.85%9 967
BLUEBIRD BIO INC199.68%8 385